William Saunderson-Meyer on Ivermectin as an alternative for Covid

Loading player...
William Saunderson-Meyer outlines the contradictories in research around Ivermectin all around the world. The drug has become one of most hotly debated topics over the last twelve months, given its apparent miracle-like effects at preventing Covid-19, despite full clinical trials having not been conducted. Learn more about your ad choices. Visit megaphone.fm/adchoices
1 Jul 2021 9AM English South Africa Investing · Business News

Other recent episodes

SA's Competition Commission has become a handbrake on the economy: Rob Rose

Bryan Brownrigg was never a currency trader. He sold foreign exchange to Standard Bank's institutional clients for 23 years. But when the Competition Commission decided that 28 banks had run a single conspiracy to rig the rand, his name went into the complaint anyway, and it took a decade and…
11 Sep 7AM 20 min

He built a $1.5bn bank. Now Revolut, Discovery Bank and PEP are circling

In this interview with Irakli Rekhviashvili, Tyme Group co-founder Coenraad Jonker gives his take on what actually protects a digital bank once the competition catches up, and why he thinks the old rules of banking no longer apply. On competitive advantage, he says: "I'm saying to my guys increasingly, I…
11 Sep 7AM 50 min